Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
19.08
+0.11 (0.58%)
Mar 9, 2026, 3:19 PM EDT - Market open
Legend Biotech Analyst Ratings
Total Analysts
14
Consensus Rating
Buy
Price Target
$63.46
Upside
+232.60%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $90 → $80 | Buy | Maintains | $90 → $80 | +319.29% | Feb 4, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $50 | Strong Buy | Maintains | $60 → $50 | +162.05% | Jan 22, 2026 |
| TD Cowen | TD Cowen | Strong Buy → Hold Downgrades $62 → $21 | Strong Buy → Hold | Downgrades | $62 → $21 | +10.06% | Jan 22, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $66 | Buy | Maintains | $66 | +245.91% | Jan 20, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $75 | Buy | Initiates | $75 | +293.08% | Jan 7, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $75 → $74 | Buy | Maintains | $75 → $74 | +287.84% | Dec 17, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $83 → $50 | Buy | Maintains | $83 → $50 | +162.05% | Dec 12, 2025 |
| UBS | UBS | Strong Buy Maintains $54 → $48 | Strong Buy | Maintains | $54 → $48 | +151.57% | Dec 8, 2025 |
| Barclays | Barclays | Buy Maintains $94 → $90 | Buy | Maintains | $94 → $90 | +371.70% | Nov 13, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $75 → $74 | Buy | Maintains | $75 → $74 | +287.84% | Nov 13, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $66 → $75 | Buy | Maintains | $66 → $75 | +293.08% | Nov 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $75 → $60 | Strong Buy | Maintains | $75 → $60 | +214.47% | Oct 17, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $78 → $76 | Buy | Maintains | $78 → $76 | +298.32% | Oct 9, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $55 → $66 | Buy | Initiates | $55 → $66 | +245.91% | Aug 27, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $77 → $78 | Buy | Maintains | $77 → $78 | +308.81% | Aug 25, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $75 → $77 | Buy | Maintains | $75 → $77 | +303.56% | Aug 12, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.